The Pharma world is seeing a big opportunity in GLP-1s – the new innovative fast emerging drugs for diabetes & obesity. Kiran ...

Norway in May, significantly more than in April and the same month last year. However, as other drive types also ...

Amgen (NASDAQ:AMGN) today announced new interim results from the global Phase 3 DeLLphi-304 trial showing IMDELLTRA® (tarlatamab-dlle) reduced the risk of death by 40% and significantly extended ...

Tesla's car sales fell sharply in several European markets including Sweden and Portugal in May, a fifth consecutive monthly ...

The executives knew that Musk had, in fact, canceled the low-cost vehicle, which many investors called the Model 2, and ...

Revenue fell short of Wall Street expectations, and Tesla shares have now plunged over 40% year to date, according to CNBC. Musk, who created DOGE after backing Donald Trump's 2024 re-election bid ...

China responded to President Trump on Monday, accusing the US of violating their trade agreement and has vowed to protect its ...

A recent analysis by UBS reveals a notable decline in Tesla’s brand appeal among consumers. The data shows that only 18% of ...

Elon Musk's departure from the Trump administration means investors will hope he refocuses on his sprawling empire. Now what?